Table 2.
NCAPH expression association with clinical pathological characteristics (logistic regression).
| Characteristics | Total (N) | Odds Ratio(OR) | P value |
|---|---|---|---|
| T stage (T2&T3&T4 vs. T1) | 510 | 1.932 (1.329–2.822) | < 0.001 |
| N stage (N1&N2&N3 vs. N0) | 501 | 1.444 (0.997–2.099) | 0.053 |
| M stage (M1 vs. M0) | 369 | 2.226 (0.963–5.582) | 0.070 |
| Pathologic stage (Stage III&Stage IV vs. Stage I&Stage II) | 505 | 1.574 (1.029–2.427) | 0.038 |
| Primary therapy outcome (PR&CR vs. PD&SD) | 426 | 0.562 (0.357–0.878) | 0.012 |
| Gender (Male vs. Female) | 513 | 1.671 (1.179–2.375) | 0.004 |
| Race (Black or African American&White vs. Asian) | 446 | 1.268 (0.276–6.500) | 0.758 |
| Age (> 65 vs. ≤ 65) | 494 | 0.635 (0.444–0.904) | 0.012 |
| Residual tumor (R1&R2 vs. R0) | 361 | 1.710 (0.636–5.059) | 0.301 |
| Anatomic neoplasm subdivision (Right vs. Left) | 498 | 1.017 (0.710–1.456) | 0.927 |
| Anatomic neoplasm subdivision2 (Peripheral Lung vs. Central Lung) | 189 | 1.354 (0.737–2.499) | 0.330 |
| Number_pack_years_smoked (≥ 40 vs. < 40) | 351 | 1.756 (1.151–2.690) | 0.009 |
| Smoker (Yes vs. No) | 499 | 2.566 (1.531–4.420) | < 0.001 |